---
edited: 2024-03-02
tags:
  - medicine
---
Acute [[Notes/Inflammation|Inflammation]] of alveoli leading to flooding of alveoli with exudates 
	1. Fever
	2. Cough (purulent)
	3. Hypoxia: [[Respiratory failure]], Resultant [[Dyspnea]] 
	4. [[Chest Pain]] if parietal pleura inflamed

### Pathology
- Congestion, Red, Grey, Resolution
- [[Respiratory bacteria]] 
- [[Staphylococcus aureus]]: [[Pneumatocele]] which is [[Lung abscess]] 
- Commonest virus: [[RSV]]
- Neonates: [[group B Streptococcus]]
- Infants with [[HIV]]: [[Pneumocystis jirovecii]] 

### Vitals
- Child with Difficulty breathing: [[Respiration]]  

#### Examination
- **Inspection:** Decreased chest movement on affected side
- **Palpation:** increased Vocal fremitus
- **Percussion:** dullness over affected lobe
- **Auscultation:** Bronchial [[Lung Sounds]], Coarse [[Crackles (rales)]], Wheezing

### Severity assessment
Severe CAP = ≥1 major criteria, or ≥3 minor criteria.
- Major:
	- septic shock with need for vasopressors,
	- respiratory failure requiring mechanical ventilation.
- Minor:
	- respiratory rate ≥30 breaths/min; PaO2/FiO2 ratio ≤ 250;
	- Multi-lobar infiltrates;
	- confusion/disorientation;
	- uremia (blood urea nitrogen ≥ 20 mg/dL);
	- leukopenia (white blood cell count < 4,000 cells/mm3);
	- thrombocytopenia (platelet count < 100,000/mm3);
	- hypothermia (temperature < 36C);

### Management
- [[CURB-65 score]] 
- Pneumonia severity index

##### Empiric antibiotics
| Risk                    | Therapy     | Activity                        | Drugs |
| ----------------------- | ----------- | ------------------------------- | ----- |
| Low                     | Monotherapy | Pneumococcus, Pseudomonas       |       |
| High                    | Combination | MRSA, Pneumococcal, Pseudomonas |       |
| High risk for mortality | Combination | MRSA, Pneumococcal, Pseudomonal |       |
- [[Pseudomonas aeruginosa]]
- [[Streptococcus pneumoniae]] 
- [[Staphylococcus aureus]] 

| Patient Population                                                                | Empiric Treatment Options                                                                                                                                                                                                                                                                                                                                                                                                      |
| --------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Healthy outpatient adults                                                         | - Amoxicillin 1 g three times daily OR<br> - Doxycycline 100 mg twice daily OR<br> - Macrolide (azithromycin 500 mg on first day then 250 mg daily or clarithromycin 500 mg twice daily or clarithromycin extended release 1,000 mg daily) only in areas with >25% pneumococcal resistance to macrolides                                                                                                                       |
| Outpatient adults with comorbidities                                              | - Combination therapy: <br>   -- Amoxicillin/clavulanate (500 mg/125 mg three times daily, 875 mg/125 mg twice daily, or 2,000 mg/125 mg twice daily) OR <br>   -- Cephalosporin (cefpodoxime 200 mg twice daily or cefuroxime 500 mg twice daily) <br>   AND <br>   -- Macrolide (azithromycin 500 mg daily, clarithromycin 500 mg twice daily or extended release 1,000 mg once daily) <br> - Doxycycline 100 mg twice daily |
| Inpatient adults with non-severe CAP without risk factors for MRSA or pseudomonas | - Combination therapy: <br>   -- β-lactam (ampicillin 1 sulbactam 1.5–3 g every 6 h, cefotaxime 1–2 g every 8 h, ceftriaxone 1–2 g daily, or ceftaroline 600 mg every 12 h) <br>   AND <br>   -- Macrolide (azithromycin 500 mg daily or clarithromycin 500 mg twice daily) <br> - Monotherapy: <br>   -- Respiratory fluoroquinolone (levofloxacin 750 mg daily, moxifloxacin 400 mg daily)                                   |
| Adults hospitalized with severe CAP                                               | - β-lactam plus a macrolide <br> - β-lactam plus a respiratory fluoroquinolone                                                                                                                                                                                                                                                                                                                                                 |
| Adults hospitalized with contraindications                                        | - Combination therapy: <br>   -- β-lactam (ampicillin 1 sulbactam, cefotaxime, ceftaroline, or ceftriaxone) <br>   AND <br>   -- Doxycycline 100 mg twice daily                                                                                                                                                                                                                                                                |
| Empiric treatment options for MRSA                                                | - Vancomycin (15 mg/kg every 12 h, adjust based on levels) <br> - Linezolid (600 mg every 12 h)                                                                                                                                                                                                                                                                                                                                |
| Empiric treatment options for P. aeruginosa                                       | - Piperacillin-tazobactam (4.5 g every 6 h) <br> - Cefepime (2 g every 8 h) <br> - Ceftazidime (2 g every 8 h) <br> - Aztreonam (2 g every 8 h) <br> - Meropenem (1 g every 8 h) <br> - Imipenem (500 mg every 6 h)                                                                                                                                                                                                            |
### Complications
- 
### Branches
- [[Atypical pneumonia]] 
- [[Recurrent pneumonia]] 
- [[Nosocomial pneumonia]] 



